Malaysia's Pharmaniaga buys 14 million doses of China's Sinovac COVID vaccine

Malaysia Pharmaniaga Bhd has signed an agreement with China’s Sinovac to purchase 14 million doses of ready-to-fill COVID-19 vaccines and later to manufacture the vaccine domestically, it said on Tuesday. Pharmaniaga said in a bourse filing that the company will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how. Group Managing Director Zulkarnain Md Eusope said the company has a monthly fill-and-finish capacity of two million doses and that Sinovac’s vaccine will be the first to be manufactured in Malaysia.